45 results on '"Paus, Sebastian"'
Search Results
2. Verbesserung der Versorgung von Patientinnen und Patienten mit spastischer Bewegungsstörung nach Schlaganfall
3. Dystonien: Diagnostische und therapeutische Herausforderungen
4. A Phase 3, Open-Label, Multicenter Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia
5. A Phase 3, Open-Label, Multi-Center Trial to Evaluate the Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults with Isolated Cervical Dystonia (P12-11.002)
6. Aneurysmal Subarachnoid Hemorrhage during the Shutdown for COVID-19
7. Erratum: Behandlung der Sialorrhoe mit Botulinum Neurotoxin Typ A – Konsentierte Praxisempfehlungen für Kinder und Erwachsene
8. Behandlung der Sialorrhoe mit Botulinum Neurotoxin Typ A – Konsentierte Praxisempfehlungen für Kinder und Erwachsene
9. Transcript-Specific Loss-of-Function Variants in VPS16 Are Enriched in Patients With Dystonia
10. Recurrent Pontine Strokes in a Young Male
11. Disentangling motor planning and motor execution in unmedicated de novo Parkinson's disease patients: An fMRI study
12. Mirror movements and blepharoclonus as novel phenomena in hereditary diffuse leukoencephalopathy with spheroids
13. High prevalence of olfactory dysfunction in cervical dystonia
14. Teaching Video NeuroImages: Propriospinal myoclonus as a sequela of Guillain-Barré syndrome
15. Zervikale Dystonien
16. Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy
17. Psychogene neurologische Störungen: Klinik und elektrophysiologische Diagnostik
18. Video-EEG findings in acute bithalamic-midbrain ischemia
19. Depression in blepharospasm: a question of facial feedback?
20. Expanded phenotype and hippocampal involvement in a novel compound heterozygosity of adult PLA2G6 associated neurodegeneration (PARK14)
21. Botulinum toxin therapy for treatment of spasticity in multiple sclerosis: review and recommendations of the IAB-Interdisciplinary Working Group for Movement Disorders task force
22. Central Pain Processing in Early-Stage Parkinson's Disease: A Laser Pain fMRI Study
23. Sustained Effect of Botulinum Neurotoxin in Myoclonus Owing to Epilepsia Partialis Continua
24. Stimulation induced hypogeusia in thalamic deep brain stimulation for tremor: an underestimated yet common side effect
25. 26. Differences in the management of cervical dystonia in the United States (US) versus Europe (EU): the patients’ perspective
26. Modulation of the Cerebello-Thalamo-Cortical Network in Thalamic Deep Brain Stimulation for Tremor
27. Abnormal Movement Preparation in Task-Specific Focal Hand Dystonia
28. Isolated spasticity in sporadic Creutzfeldt-Jakob disease
29. Spontaneous unwelcome orgasms due to pramipexole and ropinirole
30. A case of tremor reduction and almost complete ageusia under bilateral thalamic (VIM) deep brain stimulation in essential tremor—a therapeutic dilemma
31. Poster 130 Sustained Efficacy of IncobotulinumtoxinA (XEOMIN; botulinum neurotoxin type A, free from accessory proteins) in Cervical Dystonia Demonstrated by Investigator- and Patient-rated Outcomes
32. Stochastic resonance therapy in Parkinson's disease
33. Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study
34. Motor complications in patients form the German Competence Network on Parkinson's disease and the DRD3 Ser9Gly polymorphism
35. Genetic association study of the P‐type ATPase ATP13A2 in late‐onset Parkinson's disease
36. Apraxia of lid opening mimicking ptosis in compound heterozygosity for A467T and W748S POLG1 mutations
37. TheDRD2 TaqIA polymorphism and demand of dopaminergic medication in Parkinson's disease
38. Bright light therapy in Parkinson's disease: A pilot study
39. Neutralizing Antibodies Against Botulinum Toxin A After a Wasp Sting
40. Acute Hebephrenia
41. Systematic screening for mutations in the human N-methyl-D-aspartate receptor 1 gene in schizophrenic patients from the German population
42. Association study of dopamine D2, D3, D4 receptor and serotonin transporter gene polymorphisms with sleep attacks in Parkinson's disease
43. Lack of association between the interleukin-1 alpha (−889) polymorphism and early-onset Parkinson's disease
44. Sleep attacks, daytime sleepiness, and dopamine agonists in Parkinson's disease
45. Transcriptional profiling in human epilepsy: expression array and single cell real-time qRT-PCR analysis reveal distinct cellular gene regulation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.